The effectiveness of endoscopy in the management of dyspepsia: A qualitative systematic review

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 335-346

  Ofman, Joshua J ^a   Rabeneck, Linda ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE;

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DRUG INDUCED DISEASE; DYSPEPSIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PEPTIC ULCER; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RESOURCE ALLOCATION; REVIEW;

ANXIETY; COST-BENEFIT ANALYSIS; DECISION MAKING; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; HEALTH RESOURCES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; UNITED STATES;

EID: 0033104975     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00016-9     Document Type: Review

References (72)

1. Brook R.H. Quality of care do we care? Ann Intern Med. 115:1991;486-490.
2. Kahn K.L., Greenfield S. The efficacy of endoscopy in the evaluation of dyspepsia. A review of the literature and development of a sound strategy. J Clin Gastroenterol. 8:1986;346-358.
3. Talley N.J., Colin-Jones D., Koch K.L., et al. Functional dyspepsia a classification with guidelines for diagnosis and management . Gastroenterol Int. 4:1991;145-160.
4. Jones R., Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ. 298:1989;30-32.
5. Drossman D.A., Li Z., Andruzzi E., et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 38:1993;1569-1580.
6. Jones R. Upper gastrointestinal endoscopy - a view from general practice. J R Coll Gen Pract. 36:1986;6-8.
7. Marsland D.W., Wood M., Mayo F. Content of family practice. Part I. Rank order of diagnoses by frequency. Part II. Diagnosis by disease category and age/sex distribution. J Fam Pract. 3:1976;37-68.
8. Rabeneck L. Managing dyspepsia is prompt endoscopy the way to go? Gastroenterology. 108:1995;1324-1326.
9. Jones R. When is endoscopy appropriate in dyspepsia? Am J Gastroenterol. 88:1993;981-982.
10. Johnsen R. Endoscopy why and when . Scand J Prim Health Care. 8:1990;187-188.
11. Malagelada J.R. When and how to investigate the dyspeptic patient. Scand J Gastroenterol. 182:(suppl):1991;70-74.
12. Axon A.T. Chronic dyspepsia who needs endoscopy? Gastroenterology. 112:1997;1376-1380.
13. Colin-Jones D.G. When should endoscopy (or radiology) be used in dyspepsia and peptic ulcer disease? Aliment Pharmacol Ther. 1:(suppl 1):1987;548S-555S.
14. Williams B., Luckas M., Ellingham J.H., et al. Do young patients with dyspepsia need investigation? Lancet. 2:1988;1349-1351.
15. Fennerty M.B. Empirical H2 blocker therapy or prompt endoscopy in the management of dyspepsia. Gastrointest Endosc. 41:1995;529-530.
16. Fendrick A.M., Chernew M.E., Hirth R.A., Bloom B.S. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 123:1995;260-268.
17. Silverstein M.D., Petterson T., Talley N.J. Initial endoscopy or empirical therapy with or without testing for Helicobacter Pylori for dyspepsia a decision analysis . Gastroenterology. 110:1996;72-83.
18. Patel P., Mendall M.A., Khulusi S., et al. Salivary antibodies to Helicobacter pylori screening dyspeptic patients before endoscopy . Lancet. 344:1994;511-512.
19. Mansi C., Mela G.S., Savarino V., et al. Open access endoscopy a large-scale analysis of its use in dyspeptic patients . J Clin Gastroenterol. 16:1993;149-154.
20. Heatley R.V. Open-access upper gastrointestinal endoscopy visions of the future or the past? Br J Hosp Med. 51:1994;366-369.
21. Hallissey M.T., Allum W.H., Jewkes A.J., et al. Early detection of gastric cancer. BMJ. 301:1990;513-515.
22. Nyren O. Therapeutic trial in dyspepsia its role in the primary care setting . Scand J Gastroenterol. 182:(suppl):1991;61-69.
23. Bytzer P. Diagnosing dyspepsia any controversies left? Gastroenterology. 110:1996;302-306.
24. Endoscopy in the evaluation of dyspepsia. Ann Intern Med. 102:1985;266-269.
25. Froehlich F., Pache I., Burnand B., et al. Underutilization of upper gastrointestinal endoscopy. Gastroenterology. 112:1997;690-697.
26. Froehlich F., Burnand B., Pache I., et al. Overuse of upper gastrointestinal endoscopy in a country with open-access endoscopy a prospective study in primary care . Gastrointest Endosc. 45:1997;13-19.
27. Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol. 91:1996;1773-1777.
28. Sobala G.M., Crabtree J.E., Pentith J.A., et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 338:1991;94-96.
29. Patel P., Khulusi S., Mendall M.A., et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 346:1995;1315-1318.
30. Ofman J.J., Etchason J., Fullerton S., et al. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia clinical and economic consequences . Ann Intern Med. 126:1997;280-291.
31. Showstack J.A., Schroeder S.A., Steinberg H.R. Evaluating the costs and benefits of a diagnostic technolgy the case of upper gastrointestinal endoscopy . Med Care. 19:1981;498-509.
32. Cook D.J., Mulrow C.D., Haynes R.B. Systematic reviews synthesis of best evidence for clinical decisions . Ann Intern Med. 126:1997;376-380.
33. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials is blinding necessary? Control Clin Trials. 17:1996;1-12.
34. Critical Appraisal of Studies. Cochrane Collaboration Handbook (updated September 1997). The Cochrane Library (database on disk and CDROM). In: Mulrow CD, Oxman AD, eds. Oxford: The Cochrane Collaboration; 1997:96-109.
35. Talley N.J., Weaver A.L., Tesmer D.L., Zinsmeister A.R. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 105:1993;1378-1386.
36. Mansi C., Savarino V., Mela G.S., et al. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol. 88:1993;1011-1015.
37. Starmans R., Muris J.W., Fijten G.H., et al. The diagnostic value of scoring models for organic and nonorganic gastrointestinal disease, including the irritable-bowel syndrome. Med Decis Making. 14:1994;208-216.
38. Goulston K.J., Dent O.F., Mant A., et al. Use of H2-receptor antagonists in patients with dyspepsia and heartburn a cost comparison . Med J Aust. 155:1991;20-26.
39. Bytzer P., Hansen J.M., Schaffalitzky de Muckadell O.B. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 343:1994;811-816.
40. Brignoli R., Watkins P., Halter F. The Omega-Project - a comparison of two diagnostic strategies for risk- and cost-oriented management of dyspepsia. Eur J Gastroenterol Hepatol. 1997;337-433.
41. Longstreth G.F. Long-term costs after gastroenterology consultation with endoscopy versus radiography in dyspepsia. Gastrointest Endosc. 38:1992;23-26.
42. Thompson W.G. Dyspepsia is a trial of therapy appropriate? Can Med Assoc J. 153:1995;293-299.
43. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner. 232:1988;75-78.
44. Grimm I.S., Shaheen N.J. Dyspepsia algorithms and the value of endoscopy. Gastroenterology. 113:1997;1801-1802.
45. Morris C., Chapman R., Mayou R. The outcome of unexplained dyspepsia. A questionnaire follow-up study of patients after endoscopy. J Psychosom Res. 36:1992;751-757.
46. Khan K.S., Daya S., Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med. 156:1996;661-666.
47. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69.
48. Talley N.J. The role of Helicobacter pylori in nonulcer dyspepsia. A debate - against. Gastroenterol Clin North Am. 22:1993;153-167.
49. Greenberg R.E., Bank S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med. 150:1990;2053-2055.
50. Johnsen R., Bernersen B., Straume B., et al. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ. 302:1991;749-752.
51. Talley N.J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 106:1994;1174-1183.
52. Velduyzen van Zanten S.J. A systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trials and functional dyspepsia. Scand J Gastroenterol. 199:(suppl):1993;40-43.
53. Hungin A.P., Thomas P.R., Bramble M.G., et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract. 44:1994;519-521.
54. Mendall M.A., Goggin P.M., Marrero J.M., et al. Role of Helicobacter pylori serology in screening prior to endoscopy. Eur J Gastroenterol Hepatol. 4:1992;713-717.
55. Tham T.C., Van Dam J. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Gastrointest Endosc. 43:1996;532-534.
56. Overholt B.F., Hargrove R.L., Farris R.K., Porter F.R. Primary panendoscopy. Gastrointest Endosc. 33:1987;1-3.
57. Naji S.A., Brunt P.W., Hagen S., et al. Improving the selection of patients for upper gastrointestinal endoscopy. Gut. 34:1993;187-191.
58. Fjosne U., Kleveland P.M., Waldum H., et al. The clinincal benefit of routine upper gastrointestinal endoscopy. Scand J Gastroenterol. 21:1986;433-440.
59. Stevenson G.W., Norman G., Frost R., Somers S. Barium meal or endoscopy? A prospective randomized study of patient preference and physician decision making. Clin Radiol. 44:1991;317-321.
60. Hansen J.M., Bytzer P., Bondesen S., Schaffalitzky de Muckadell O.B. Efficacy and outcome of an open access endoscopy service. Dan Med Bull. 38:1991;288-290.
61. Briggs A.H., Sculpher M.J., Logan R.P., et al. Cost effetiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ. 312:1996;1321-1325.
62. Mucklow J.C., Haydox A.R., Wood K.M., et al. Cost-effective management of dyspepsia. Br J Med Econ. 10:1996;119-127.
63. Rubin R.J., Cascade E.F., Barker R.C., et al. Management of dyspepsia a decision analysis model . Am J Managed Care. 2:1998;647-655.
64. Ebell M.H., Warbasse L., Brenner C. Evaluation of the dyspeptic patient a cost-utility study . J Fam Pract. 44:1997;545-555.
65. Pruitt R.E., Truss C.D. Endoscopy, gastric ulcer, and gastric cancer. Follow-up endoscopy for all gastric ulcers? Dig Dis Sci. 38:1993;284-288.
66. Thompson W.G. Dyspepsia is a trial of therapy appropriate? Can Med Assoc J. 153:1995;293-299.
67. Matley P.J., Dent D.M., Madden M.V., Price S.K. Gastric carcinoma in young adults. Ann Surg. 208:1988;593-596.
68. Horrocks J.C., De Dombal F.T. Clinical presentation of patients with "dyspepsia." Detailed symptomatic study of 360 patients. Gut. 19:1978;19-26.
69. Longo W.E., Zucker K.A., Zdon M.J., Modlin I.M. Detection of early gastric cancer in an aggressive endoscopy unit. Am Surg. 55:1989;100-104.
70. Holdstock G., Bruce S. Endoscopy and gastric cancer. Gut. 22:1981;673-676.
71. Newbold K.M., Thompson H., Dykes P.W. The effect of routine endoscopy on the detection rate of T1 gastric cancer (early gastric cancer) in Birmingham. Endoscopy. 21:1989;56-59.
72. Wile A.G., Hourani L., Schell M.J. The contributions of patient factors, physician delay, and tumor biology to the outcome of gastric cancer. Am Surg. 59:1993;850-854.